MYC and neoplasm: Furthermore, “Hypoxia,” “Glycolysis,” “MTORC1 Signaling,” and “MYC Targets V1” were upregulated in primary tumor tissues and remained elevated in the UPCI-SCC-090 cell line after JQ1 treatment.